Expression of cytoplasmic retinoic acid-binding proteins and nuclear receptors in squamous-cell carcinomas in vitro
β Scribed by Jeanette Kley; Wolfgang Hoffmann; Michael Bamberg; H. Peter Rodemann
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- French
- Weight
- 50 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Retinoids have been described to be potent modulators of cell proliferation, differentiation and apoptosis in various types of squamous-cell carcinoma (SCC) and myeloid cancer cells in vitro (Bollag and Holdener, 1992;Lotan et al., 1995). It has also been demonstrated that treatment of cells with retinoic acid (RA) in combination with ionizing radiation resulted in significantly enhanced radiation cytotoxicity. In these studies, the reduction of cell survival could be attributed to a supra-additive inhibition of clonogenic activity and concomitantly to a stimulation of differentiation processes induced either by retinoids and or interferon-a in combination with irradiation (Hoffmann et al., 1994). The underlying molecular mechanism of these effects is not understood. It is thought that the cell biological activities of retinoids, and especially the radiosensitizing effect of RA, result from changes in gene expression mediated via the binding of RA to CRABP I/II and the transport of RA into the nucleus. It then can bind to the nuclear receptors RAR or RXR or to the dimer forms of these subunits (Mangelsdorf et al., 1995). Subsequently, the nuclear receptor is able to bind to specific RA-response elements of specific genes which are involved in the regulation of cell proliferation and differentiation. To study the underlying mechanism of the growthinhibitory and radiosensitizing effects of RA, we analyzed in various SCC lines the basal level as well as the RA-and/or irradiation-modulated gene expression of RAR, RXR and CRABP I/II. To increase the level of sensitivity, we therefore established the method of semi-quantitative RT-PCR.
π SIMILAR VOLUMES
Pre-clinical data indicate that retinoid/interferon combinations have significant activity in modulating malignant cell growth, differentiation and programmed cell death in different hematologic and solid tumor systems . Clinically, the combination of 13-cis retinoic acid (13cRA) and interferon-a (I
The retinoblastoma gene (RB) is a typical tumor-suppressor gene. Inactivation of RB has been shown in a variety of human cancers, including esophageal squamous-cell carcinomas. In the present study, samples of normal esophageal squamous epithelium (n β«Ψβ¬ 10), severe squamous-cell dysplasias (n β«Ψβ¬ 1
The role of retinoic acid receptor (RAR) expression in sensitivity to N-(4-hydroxyphenyl)retinamide (4HPR or fenretinide) as well as on the tumorigenicity of human ovarian carcinoma cells was examined. Two human ovarian cancer cell lines, A2780 and IGROV-1, with a 10-fold difference in sensitivity t